Waltham, MA 2/1/10; Waltham, MA 2/2/10—Thermo Fisher Scientific has completed its second and third acquisitions this year (see IBO 1/31/10). On February 1, Thermo announced a definitive agreement to purchase Finnzymes, a provider of PCR solutions, including reagents, instruments, consumables and kits, including the Phire and Phusion DNA polymerases. Based in Espoo, Finland, Finnzymes has 90 employees and generated 2009 revenues of $20 million. Terms were not disclosed. “The addition of Finnzymes’ innovative enzyme portfolio and unique PCR instrument platform strengthens our broad range of life science reagents and consumables, as well as our specialty diagnostics product offering,” stated Thermo Fisher Scientific President and CEO Marc N. Casper. Finnzymes will be integrated primarily into Thermo’s Analytical Technologies segment, with some equipment and consumables added to the Laboratory Products and Services segment. The transaction, which is expected to close during the first quarter, is not expected to have a material impact on 2010 financial results. Thermo has also acquired NovaWave Technologies, a developer and manufacturer of chemical sensors for environmental monitoring, industry and safety applications, for an undisclosed amount. NovaWave had 2009 revenues of $4 million and has 18 employees. “The growing concern regarding climate change and the collective development of regulatory controls present a unique opportunity to showcase our leading Thermo Scientific line of environmental instruments,” said Greg Herrema, president of Thermo’s Analytical Instruments businesses.